Related Experiment Video
Updated: Jun 25, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
[Analysis of factors affecting long-term administration of anti-methicillin resistant Staphylococcus aureus (MRSA)
Hiroyuki Hayashi1, Takashi Matsuzaki, Yasuko Mizuno
1Department of Pharmacy, Yokohama City Seibu Hospital, St. Marianna University, Yokohama, Japan. hayashi8@marianna-u.ac.jp
Abstract:
In this study, we aimed to determine an index of anti-MRSA drugs for long-term treatment. We examined adult patients to whom the anti-MRSA drugs arbekacin sulfate (ABK), vancomycin hydrochloride (VCM), and teicoplanine (TEIC) had been administered in the St. Marianna University School of Medicine, Yokohama City Seibu Hospital, for 1, year. The number of patients treated for>or==14 days was 22 (31%) among 71 patients. Immunosuppressive agent positivity (p=0.07), albumin (ALB) level of
Insights
Long-term treatment with anti-MRSA drugs like arbekacin sulfate (ABK) is often necessary for patients with low albumin levels. Careful consideration of treatment and nutrition is crucial for effective drug use.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant treatment challenge.
- Long-term administration of anti-MRSA drugs requires careful patient selection and management.
- Arbekacin sulfate (ABK), vancomycin hydrochloride (VCM), and teicoplanine (TEIC) are key agents for MRSA infections.
Purpose of the Study:
- To identify factors influencing the need for long-term anti-MRSA drug therapy.
- To establish an index for guiding long-term treatment decisions for MRSA infections.
- To evaluate the impact of patient characteristics on treatment duration.
Main Methods:
- Retrospective analysis of 71 adult patients receiving ABK, VCM, or TEIC.
- Univariate and multivariate logistic regression analyses were performed.
- Key variables analyzed included immunosuppressive agent use, albumin levels, CRP, %STAB, and time to blood drug level measurement.
Main Results:
- Only 31% (22 out of 71) of patients received treatment for 14 days or longer.
- Low albumin levels (≤2.5 g/dL) were identified as a significant predictor for long-term treatment necessity (p=0.03).
- Elevated C-reactive protein (CRP) levels (>or==10 mg/dL) also showed a trend towards significance (p=0.01).
Conclusions:
- Low serum albumin levels are a critical factor indicating the need for cautious long-term anti-MRSA therapy.
- Integrated management of treatment and nutritional support is essential for patients requiring prolonged drug administration.
- Optimizing early blood drug level monitoring is crucial for appropriate and effective use of anti-MRSA agents.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Effectiveness
Development of Antibiotic Resistance